Alert Icon

Beware of scams

We are aware of scams coming from email and social media where people try to impersonate us. We will never ask you for money or your bank details.

Learn more about what to look out for and how to protect yourself


Success Story 11 March 2022

Region/Nation UK wide
Sector Life Sciences
Programme Regional Angels

Part of a cluster of biotech companies in Aberdeen, Elasmogen uses its bespoke technology platform to isolate innovative drugs for treating cancers and auto-immune diseases.

With a strong foundation of intellectual property and a healthy pipeline of new programmes, Elasmogen had progressed several innovative drugs to the late pre-clinical stage. Finance is vital at this early research and development stage.

Image of man conducting experiment

Funding from Regional Angels Programme delivery partner Deepbridge has added value to the company’s platform, processes and products – and helped to retain its talented team. Elasmogen is now in a position to consider its next major milestone: entering clinical trials.

It has transformed our ability to demonstrate the advantages of our technology over the competition. Caroline Barelle CEO